-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-244-fullreport.pdf
December 01, 2019 - Population – infants (29 days to 1 year) (specify age range): No.
q.
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-212-fullreport.pdf
September 01, 2018 - Population – infants (29 days to 1 year) (specify age range): No.
q.
-
www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-244-fullreport.pdf
December 01, 2019 - Population – infants (29 days to 1 year) (specify age range): No.
q.
-
www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-212-fullreport.pdf
September 01, 2018 - Population – infants (29 days to 1 year) (specify age range): No.
q.
-
www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-245-fullreport.pdf
December 01, 2019 - Population – infants (29 days to 1 year) (specify age range): No.
q.
-
www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-244-fullreport.pdf
December 01, 2019 - Population – infants (29 days to 1 year) (specify age range): No.
q.
-
www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-245-fullreport.pdf
December 01, 2019 - Population – infants (29 days to 1 year) (specify age range): No.
q.
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-212-fullreport.pdf
September 01, 2018 - Population – infants (29 days to 1 year) (specify age range): No.
q.
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-244-fullreport.pdf
December 01, 2019 - Population – infants (29 days to 1 year) (specify age range): No.
q.
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-245-fullreport.pdf
December 01, 2019 - Population – infants (29 days to 1 year) (specify age range): No.
q.
-
www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-212-fullreport.pdf
September 01, 2018 - Population – infants (29 days to 1 year) (specify age range): No.
q.
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-244-fullreport.pdf
December 01, 2019 - Population – infants (29 days to 1 year) (specify age range): No.
q.
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-212-fullreport.pdf
September 01, 2018 - Population – infants (29 days to 1 year) (specify age range): No.
q.
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-245-fullreport.pdf
December 01, 2019 - Population – infants (29 days to 1 year) (specify age range): No.
q.
-
www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-238-fullreport.pdf
October 01, 2019 - Population – infants (29 days to 1 year) (specify age range): Yes; all ages in this
range.
q.
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-238-fullreport.pdf
October 01, 2019 - Population – infants (29 days to 1 year) (specify age range): Yes; all ages in this
range.
q.
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-212-fullreport.pdf
September 01, 2018 - Population – infants (29 days to 1 year) (specify age range): No.
q.
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-244-fullreport.pdf
December 01, 2019 - Population – infants (29 days to 1 year) (specify age range): No.
q.
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-245-fullreport.pdf
December 01, 2019 - Population – infants (29 days to 1 year) (specify age range): No.
q.
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/cervical-cancer-screening-2012
March 15, 2012 - associated with adverse pregnancy outcomes, such as preterm delivery, that can lead to low birthweight in infants